GrantPostedDiscretionary

DoD Rare Cancers, Resource and Community Development Award

Dept. of the Army -- USAMRAA
HT942525RCRPRCDA
Application Deadline
Oct 6, 2025
Closed
Days Remaining
0
Deadline passed
Award Ceiling
Total Program Funding
$5,600,000

Grant Opportunity Analysis

The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Rare Cancers Research Program Resource and Community Development Award, with an estimated total funding of $5.6 million aimed at enhancing research resources and clinical data related to rare cancers. This grant seeks to address critical gaps in rare cancer research, including the lack of resources, communication strategies, and data-sharing infrastructure, while emphasizing the integration of patient advocates throughout the project lifecycle. Eligible applicants include both domestic and foreign non-profit and for-profit organizations, with applications due by October 6, 2025, following a pre-application deadline of July 1, 2025. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.

Eligible Applicants

Unrestricted

Grant Documents

1 Files
HT942525RCRPRCDA_GG.pdf
PDF613 KB5/4/2025
AI Summary
The Department of Defense (DOD) is initiating the FY25 Rare Cancers Research Program Resource and Community Development Award, funding approximately $5.6 million for projects aimed at enhancing research resources and supporting clinical data related to rare cancers. Eligibility is extended to both domestic and foreign non-profit or for-profit organizations, with applications due by October 6, 2025, following a pre-application deadline of July 1, 2025. Key focus areas include integrating patient advocates throughout the project, creating robust community building strategies, and ensuring the sustainability of research platforms developed via grant funding. The program seeks to address significant gaps in rare cancer research—such as inadequate resources, lack of communication strategies, and insufficient data-sharing infrastructure. The funding supports both clinical and preclinical research, encouraging the development of extensive datasets and repositories. Ethical considerations, including the sequential involvement of patient advocates, are central to the award mechanism. A detailed two-step application process is outlined, culminating in a thorough review for scientific merit and program relevance, leading to recommendations for funding decisions by the DOD. Overall, the initiative aims to significantly improve therapeutic outcomes and knowledge-sharing within the rare cancer research community.

Related Grant Opportunities

Project Timeline

postedOriginal Opportunity PostedMay 1, 2025
deadlineApplication DeadlineOct 6, 2025

Funding Details

Est. Total Program Funding
$5,600,000
Expected Awards
5
No cost sharing required

Agency & Classification

Agency
Dept. of the Army -- USAMRAA(DOD-AMRAA)
Funding Category
Science and Technology and other Research and Development
Funding Instrument
Grant

Grantor Contact

CFDA Numbers

12.420

Official Sources